Cargando…

Evaluation of metabolic syndrome in adults of Talca city, Chile

OBJECTIVE-: Insulin resistance (IR) is an important risk factor for type 2 Diabetes Mellitus (DM2) and cardiovascular disease (CVD). Metabolic Syndrome (MS) is a clustering of metabolic alterations associated to IR; however, there is no international consensus for defining its diagnosis. Our objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mujica, Veronica, Leiva, Elba, Icaza, Gloria, Diaz, Nora, Arredondo, Miguel, Moore-Carrasco, Rodrigo, Orrego, Roxana, Vásquez, Marcela, Palomo, Ivan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397433/
https://www.ncbi.nlm.nih.gov/pubmed/18482457
http://dx.doi.org/10.1186/1475-2891-7-14
_version_ 1782155625194586112
author Mujica, Veronica
Leiva, Elba
Icaza, Gloria
Diaz, Nora
Arredondo, Miguel
Moore-Carrasco, Rodrigo
Orrego, Roxana
Vásquez, Marcela
Palomo, Ivan
author_facet Mujica, Veronica
Leiva, Elba
Icaza, Gloria
Diaz, Nora
Arredondo, Miguel
Moore-Carrasco, Rodrigo
Orrego, Roxana
Vásquez, Marcela
Palomo, Ivan
author_sort Mujica, Veronica
collection PubMed
description OBJECTIVE-: Insulin resistance (IR) is an important risk factor for type 2 Diabetes Mellitus (DM2) and cardiovascular disease (CVD). Metabolic Syndrome (MS) is a clustering of metabolic alterations associated to IR; however, there is no international consensus for defining its diagnosis. Our objective was to evaluate the prevalence and characteristics of MS identified by the ATP III and IDF criteria in adults from Talca city. RESEARCH AND METHODS-: We studied 1007 individuals, aged 18–74, and residents from Talca. MS subjects were defined according to ATP III (three altered factors) and IDF criteria (patients with waist circumference >80/90 cm (W/M) and two others altered factors). RESULTS-: The prevalence of metabolic syndrome according to the IDF and ATP III criteria was 36.4% and 29.5%, respectively after adjustment for age and sex. The agreement for both criteria was 89%. The prevalence in men was higher than in women for both MS definitions, although not significant. MS probability increased with age, and the highest risk was in the 57–68 age group (ATP-MS) and 53–72 age group (IDF-MS). Hypertension, high triglycerides and abdominal obesity are the most frequent alterations in MS. CONCLUSION-: MS prevalence in adults was higher when diagnosed with IDF than with ATP criterion; in both, age is directly related with the MS presence. The MS subjects showed higher levels of blood pressure, waist circumference and plasma triglycerides. Considering our results, it is worrisome that one third of our population has a high risk of developing DM2 and CVD in the future.
format Text
id pubmed-2397433
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23974332008-05-29 Evaluation of metabolic syndrome in adults of Talca city, Chile Mujica, Veronica Leiva, Elba Icaza, Gloria Diaz, Nora Arredondo, Miguel Moore-Carrasco, Rodrigo Orrego, Roxana Vásquez, Marcela Palomo, Ivan Nutr J Research OBJECTIVE-: Insulin resistance (IR) is an important risk factor for type 2 Diabetes Mellitus (DM2) and cardiovascular disease (CVD). Metabolic Syndrome (MS) is a clustering of metabolic alterations associated to IR; however, there is no international consensus for defining its diagnosis. Our objective was to evaluate the prevalence and characteristics of MS identified by the ATP III and IDF criteria in adults from Talca city. RESEARCH AND METHODS-: We studied 1007 individuals, aged 18–74, and residents from Talca. MS subjects were defined according to ATP III (three altered factors) and IDF criteria (patients with waist circumference >80/90 cm (W/M) and two others altered factors). RESULTS-: The prevalence of metabolic syndrome according to the IDF and ATP III criteria was 36.4% and 29.5%, respectively after adjustment for age and sex. The agreement for both criteria was 89%. The prevalence in men was higher than in women for both MS definitions, although not significant. MS probability increased with age, and the highest risk was in the 57–68 age group (ATP-MS) and 53–72 age group (IDF-MS). Hypertension, high triglycerides and abdominal obesity are the most frequent alterations in MS. CONCLUSION-: MS prevalence in adults was higher when diagnosed with IDF than with ATP criterion; in both, age is directly related with the MS presence. The MS subjects showed higher levels of blood pressure, waist circumference and plasma triglycerides. Considering our results, it is worrisome that one third of our population has a high risk of developing DM2 and CVD in the future. BioMed Central 2008-05-15 /pmc/articles/PMC2397433/ /pubmed/18482457 http://dx.doi.org/10.1186/1475-2891-7-14 Text en Copyright © 2008 Mujica et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mujica, Veronica
Leiva, Elba
Icaza, Gloria
Diaz, Nora
Arredondo, Miguel
Moore-Carrasco, Rodrigo
Orrego, Roxana
Vásquez, Marcela
Palomo, Ivan
Evaluation of metabolic syndrome in adults of Talca city, Chile
title Evaluation of metabolic syndrome in adults of Talca city, Chile
title_full Evaluation of metabolic syndrome in adults of Talca city, Chile
title_fullStr Evaluation of metabolic syndrome in adults of Talca city, Chile
title_full_unstemmed Evaluation of metabolic syndrome in adults of Talca city, Chile
title_short Evaluation of metabolic syndrome in adults of Talca city, Chile
title_sort evaluation of metabolic syndrome in adults of talca city, chile
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397433/
https://www.ncbi.nlm.nih.gov/pubmed/18482457
http://dx.doi.org/10.1186/1475-2891-7-14
work_keys_str_mv AT mujicaveronica evaluationofmetabolicsyndromeinadultsoftalcacitychile
AT leivaelba evaluationofmetabolicsyndromeinadultsoftalcacitychile
AT icazagloria evaluationofmetabolicsyndromeinadultsoftalcacitychile
AT diaznora evaluationofmetabolicsyndromeinadultsoftalcacitychile
AT arredondomiguel evaluationofmetabolicsyndromeinadultsoftalcacitychile
AT moorecarrascorodrigo evaluationofmetabolicsyndromeinadultsoftalcacitychile
AT orregoroxana evaluationofmetabolicsyndromeinadultsoftalcacitychile
AT vasquezmarcela evaluationofmetabolicsyndromeinadultsoftalcacitychile
AT palomoivan evaluationofmetabolicsyndromeinadultsoftalcacitychile